Search

Your search keyword '"Cheville, John C"' showing total 154 results

Search Constraints

Start Over You searched for: Author "Cheville, John C" Remove constraint Author: "Cheville, John C" Publisher elsevier bv Remove constraint Publisher: elsevier bv
154 results on '"Cheville, John C"'

Search Results

1. Single Nucleotide Polymorphism (SNP) Chromosomal Microarray as a Diagnostic Tool for Mucinous Tubular and Spindle Cell Carcinoma: A Validation Study

6. Identification of amyloidosis of the urinary tract and prostate: Opportunities for early diagnosis & intervention in systemic disease

7. Next generation sequencing-based identification of fusion-driven renal neoplasia: A single institution experience

8. Assessment of PD-L1, TROP2, and nectin-4 expression in penile squamous cell carcinoma

12. Mass Spectrometry-Based Assessment of Prostate Cancer-Associated Crystalloids Reveals Enrichment for Growth & Differentiation Factor 15 (GDF15)

13. Deepfake Histologic Images for Enhancing Digital Pathology

15. A contemporary guide to chromosomal copy number profiling in the diagnosis of renal cell carcinoma

16. Penile squamous cell carcinoma exclusive to the shaft, with a proposal for a novel staging system

17. Progression of Chronic Kidney Disease Following Radical and Partial Nephrectomy

18. Renin Production by Juxtaglomerular Cell Tumors and Clear Cell Renal Cell Carcinoma and the Role of Angiotensin Signaling Inhibitors

20. Immunohistochemical expression of renin and GATA3 help distinguish juxtaglomerular cell tumors from renal glomus tumors

21. A diagnostic approach to paratesticular lesions with tubulopapillary architecture: a series of 16 serous borderline tumors/low-grade serous carcinoma and 14 well-differentiated papillary mesothelial tumors and mesothelioma

22. Reply to Yang Zhao, Wenda Wang, and Yushi Zhang’s Letter to the Editor re: Sounak Gupta, Christine M. Lohse, Ross Rowsey, et al. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex–associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome. Eur Urol 2022;81:229–33

23. Cytogenetics of spermatocytic tumors with a discussion of gain of chromosome 12p in anaplastic variants

24. Renal Neoplasia in Polycystic Kidney Disease: An Assessment of Tuberous Sclerosis Complex–associated Renal Neoplasia and PKD1/TSC2 Contiguous Gene Deletion Syndrome

25. Collecting duct carcinoma: A single‐institution retrospective study

26. Comparative molecular analysis of testicular Leydig cell tumors demonstrates distinct subsets of neoplasms with aggressive histopathologic features

27. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics

29. The association of salvage intravesical therapy following BCG with pathologic outcomes and survival after radical cystectomy for patients with high-grade non-muscle invasive bladder cancer: A multi-institution analysis

30. Reply to Riuko Ohashi, Arndt Hartmann, Holger Moch, and Guido Martignoni’s Letter to the Editor re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225–31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That’s the Question!

31. New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

32. Assessment of isochromosome 12p and 12p abnormalities in germ cell tumors using fluorescence in situ hybridization, single-nucleotide polymorphism arrays, and next-generation sequencing/mate-pair sequencing

34. Novel, emerging and provisional renal entities: The Genitourinary Pathology Society (GUPS) update on renal neoplasia

35. Correction to: Novel, emerging and provisional renal entities: the Genitourinary Pathology Society (GUPS) update on renal neoplasia

36. Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey

38. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis

39. Creation of a primary tumor tissue expression biomarker-augmented prognostic model for patients with metastatic renal cell carcinoma

40. Renal neoplasia with papillary architecture involving the pelvicalyceal system

41. Long-term outcomes of incidental prostate cancer at radical cystectomy

42. Secondary renal neoplasia following chemotherapy or radiation in pediatric patients

45. Integration of Comprehensive Genomic Analysis and Functional Screening of Affected Molecular Pathways to Inform Cancer Therapy

46. The association of anxiety and depression with perioperative and oncologic outcomes among patients with clear cell renal cell carcinoma undergoing nephrectomy

48. Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766–72. Partial Nephrectomy: “Geocentrism” of the 21st century in the Church of Urology?

49. Incidence of succinate dehydrogenase and fumarate hydratase–deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC

50. JAK2/PD-L1/PD-L2 (9p24.1) amplifications in renal cell carcinomas with sarcomatoid transformation: implications for clinical management

Catalog

Books, media, physical & digital resources